10 August 2017 - EMA leaflet shows how work of the Agency benefits patients.

As authoritative regulator for medicines in Europe, the EMA ensures that medicines which are prescribed and used across the European Union are safe, effective and of good quality. The best scientific experts made available through the European regulatory network for medicines carefully evaluate each new medicine and only recommend its authorisation if the benefits for the patients outweigh the risks of possible side effects.

The leaflet, entitled ‘Enabling science that works for patients’, explains that the Agency promotes science and innovation to find better medicines. EMA collaborates closely with patients to understand their point of view and to make sure that new medicines address their needs. The Agency provides scientific advice and guidance to encourage the development of new and innovative medicines, especially in areas with limited treatment options such as rare diseases and illnesses in children.

Read EMA news article